From: Human papillomavirus and bladder cancer: literature review and meta-analysis
# | Study name/subgroup name | Risk ratio | CI lower limit | CI upper limit | Weight (%) |
---|---|---|---|---|---|
1 | M.R. Barghi, 2005, Iran | 1.48 | 1.19 | 1.83 | 19.37 |
2 | H. Badawi, 2008, Egypt | 1.64 | 1.06 | 2.53 | 5.00 |
3 | G. Eslami, 2008, Iran | 1.41 | 1.22 | 1.64 | 40.42 |
4 | N. Berrada, 2013, Morocco | 1.88 | 1.26 | 2.79 | 5.97 |
5 | H. Badawi, 2018, Egypt | 1.50 | 1.26 | 1.79 | 29.24 |
6 | Arabic | 1.49 | 1.30 | 1.70 | 22.82 |
7 | W. Zengjun, 1996, China | 1.68 | 1.26 | 2.24 | 6.22 |
8 | Chaomei T.W.X.Y.L., 1998, China | 1.54 | 0.98 | 2.42 | 2.71 |
9 | W. Dinghai, 1999, China | 1.89 | 1.32 | 2.70 | 4.06 |
10 | K. Shigehara, 2009, Japan | 1.19 | 1.00 | 1.42 | 16.70 |
11 | K. Shigehara, 2010, Japan | 1.13 | 0.97 | 1.32 | 21.85 |
12 | J. Xiao, 2011, China | 1.01 | 0.90 | 1.13 | 38.88 |
13 | S.H. Kim, 2014, Korea | 1.11 | 0.88 | 1.40 | 9.57 |
14 | Asian | 1.15 | 1.05 | 1.26 | 24.55 |
15 | Smetana Z., 1995, Israel | 2.05 | 1.66 | 2.54 | 3.03 |
16 | D. Fioriti, 2003, Italy | 1.02 | 0.92 | 1.13 | 13.71 |
17 | S. Youshya, 2005, UK | 0.98 | 0.92 | 1.05 | 28.75 |
18 | T. Cai, 2010, Italy | 1.54 | 1.16 | 2.04 | 1.74 |
19 | A. Sorlozano, 2010, Spain | 1.00 | 0.90 | 1.12 | 11.66 |
20 | T. Cai, 2011, Italy | 1.37 | 1.14 | 1.65 | 4.10 |
21 | G. I. Panagiotakis, 2013, Greece | 1.00 | 0.94 | 1.07 | 33.77 |
22 | S.C. Schmid, 2015, Germany | 0.93 | 0.76 | 1.15 | 3.24 |
23 | European | 1.04 | 0.99 | 1.09 | 26.35 |
24 | M.I. Tekin, 1999, Turkey | 1.01 | 0.87 | 1.18 | 6.65 |
25 | M. Yıldızhan, 2020, Turkey | 1.04 | 1.00 | 1.08 | 93.35 |
26 | Turkic | 1.03 | 0.81 | 1.33 | 26.29 |